Updates on Genes and Genetic Mechanisms Implicated in Primary Angle-Closure Glaucoma

Area of Science:

• Ophthalmology
• Genetics
• Public Health

Background:

• Primary angle-closure glaucoma (PACG) is a leading cause of blindness, particularly prevalent in Asian populations, affecting over 30 million worldwide by 2040.
• PACG presents a significant public health concern due to its severity and higher risk of blindness compared to primary open-angle glaucoma.
• The high heritability and ethnic-specific predisposition to PACG strongly suggest a substantial genetic contribution to its development.

Purpose of the Study:

• To review and synthesize current knowledge on genetic analysis research in primary angle-closure glaucoma.
• To highlight the identified genes and loci associated with PACG across diverse ethnicities.
• To discuss the implications of genetic findings for understanding PACG etiology and potential clinical applications.

Main Methods:

• Systematic review of genetic studies on primary angle-closure glaucoma.
• Analysis of identified genes and loci associated with PACG.
• Synthesis of current understanding of genetic factors in PACG development.

Main Results:

• Several genes and loci have been successfully identified in relation to PACG across different ethnicities.
• Genetic studies have significantly advanced the understanding of cellular processes and biological pathways involved in PACG.
• The precise cellular and molecular roles of identified loci in PACG pathogenesis require further elucidation.

Conclusions:

• Genetic factors are crucial in the development of primary angle-closure glaucoma.
• Ongoing genetic research provides valuable insights into PACG's etiology and potential therapeutic targets.
• Further investigation into the functional roles of identified genetic loci is essential for future clinical applications.